To date, Hh inhibitors have been shown beneficial when used as single-agent therapy in basal cell carcinoma,30,34–36 and studies that have combined these agents with chemotherapy have failed to show clinical benefit.37 Similar to our findings, there was no correlation between baseline Gli-1 expression and survival. The gene discussed is GLI1; the disease is basal cell carcinoma.